FOR IMMEDIATE RELEASE
November 17, 2020 MADISON, WI
DNASTAR® announced today the integration of the Mastermind database from Genomenon into the Lasergene Genomics software with the release of Lasergene® 17.2.
With this integration, Lasergene users can now search and cross-reference NGS variant data from millions of PubMed publications. This searching and filtering capability is complemented by DNASTAR’s robust visualization and analysis tools for resequencing and human variant detection. Mastermind literature citations are included in the DNASTAR Variant Annotation Database and are available with every Lasergene Genomics license.
This integration gives researchers new insights into their variant data and allows for even faster discoveries for those studying human genetics, cancer, and rare diseases. “There is a natural synergy between DNASTAR’s Lasergene Genomics package and the Genomenon Mastermind database,” said Shawn Grass, Interim General Manager at DNASTAR. “Mastermind’s vast annotation database provides our genomics software customers with answers about which gene variations are most likely to negatively affect health. The next wave of insights and treatment for disease will be driven by cross-institutional collaborations like this one.”
The Real-world Evidence to validate a drug target, identify trial-eligible patients, or change a diagnosis already exists. It is buried in 39 million biomedical articles, locked behind paywalls and supplemental files most researchers never find.
Genomenon closes that gap. Fit-for-purpose AI-powered search reads 11.2 million full-text papers and 3.7 million supplemental datasets. Eighty expert scientific curators validate every finding. The result is structured, traceable, regulatory-grade Real-World Evidence at the genetic variant and patient level. Loxo@Lilly used Genomenon to add 73 variants to the RET label. In a head-to-head, Genomenon identified 83% more rare disease patients than ChatGPT plus OpenEvidence.
250+ diagnostic labs and 75 biopharma programs rely on Genomenon as the evidence layer behind precision medicine.
DNASTAR, Inc., Madison, Wisconsin, (www.dnastar.com) is a pioneer in the development and sale of software used to increase life scientists’ productivity using their desktop computer or on the Amazon Cloud. DNASTAR Lasergene supports molecular biologists, geneticists, and structural biologists in meeting virtually all of their DNA, RNA, and protein sequence needs, including Sanger and next-generation sequence assembly and analysis, protein sequence and structure analysis, protein structure prediction, antibody modeling, and protein-protein docking with easy-to-use, affordable, flexible computer software.
